Breadcrumb

[A05-05A] Glitazones in the treatment of diabetes mellitus type 2

Overview

Overview

Commission: Commission awarded on 2005-02-22 by the Federal Joint Committee (G-BA)
Status:Commission completed
Department/Division:Drug Assessment
Current document:PDF Executive summary of the final report  [PDF, 155 kB]Further documents
Contact address:to the contact form

Report documents

Report documents

PublishedDocumentSizeType 
2009-01-26 Executive summary of the final report 155 kBPDFdownload file
2009-01-26 Final report (German version) 4 MBPDFdownload file
2009-01-26 Documentation and appraisal of comments on the preliminary report (German version) 2 MBPDFdownload file
2008-06-16 Preliminary report (German version) 4 MBPDFdownload file
2007-11-12 Report plan version 2.0 (German version) 227 kBPDFdownload file
2007-11-12 Documentation and appraisal of comments on the report plan version 1.0 (German version) 5 MBPDFdownload file
2007-03-21 Amendment 3 to the report plan version 1.0 (German version) 51 kBPDFdownload file
2006-10-11 Amendment 2 to the report plan version 1.0 (German version) 122 kBPDFdownload file
2005-08-11 Amendment 1 to the report plan version 1.0 (German version) 33 kBPDFdownload file
2005-07-12 Report plan version 1.0 (German version) 164 kBPDFdownload file


At a glance

Accompanying information

Executive summary of the final report

  File-Icon  Glitazones in the treatment of diabetes mellitus type 2 [PDF, 155 kB]

Health information

Further information for consumers and patients is provided on IQWiG's health information website www.informedhealthonline.org.

Medication for type 2 diabetes

Press releases

2009-01-26 Glitazones have not yet been sufficiently investigated



Save result list

To save your search result, please copy the link below and paste it into a new tab/window.

close